IL201901A0 - Controlled release tablet formulation containing magnesium aluminometasilicate - Google Patents

Controlled release tablet formulation containing magnesium aluminometasilicate

Info

Publication number
IL201901A0
IL201901A0 IL201901A IL20190109A IL201901A0 IL 201901 A0 IL201901 A0 IL 201901A0 IL 201901 A IL201901 A IL 201901A IL 20190109 A IL20190109 A IL 20190109A IL 201901 A0 IL201901 A0 IL 201901A0
Authority
IL
Israel
Prior art keywords
controlled release
formulation containing
containing magnesium
release tablet
tablet formulation
Prior art date
Application number
IL201901A
Other languages
English (en)
Original Assignee
Jagotec Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jagotec Ag filed Critical Jagotec Ag
Publication of IL201901A0 publication Critical patent/IL201901A0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Psychology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL201901A 2007-05-17 2009-11-03 Controlled release tablet formulation containing magnesium aluminometasilicate IL201901A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0709541.7A GB0709541D0 (en) 2007-05-17 2007-05-17 Pharmaceutical excipient
PCT/IB2008/002128 WO2008142572A2 (en) 2007-05-17 2008-05-16 Controlled release tablet formulation containing magnesium aluminometasilicate

Publications (1)

Publication Number Publication Date
IL201901A0 true IL201901A0 (en) 2010-06-16

Family

ID=38234655

Family Applications (1)

Application Number Title Priority Date Filing Date
IL201901A IL201901A0 (en) 2007-05-17 2009-11-03 Controlled release tablet formulation containing magnesium aluminometasilicate

Country Status (9)

Country Link
US (1) US20100196475A1 (OSRAM)
EP (1) EP2152248A2 (OSRAM)
JP (1) JP2010527347A (OSRAM)
CN (1) CN101677962B (OSRAM)
AU (1) AU2008252481B2 (OSRAM)
CA (1) CA2684366A1 (OSRAM)
GB (1) GB0709541D0 (OSRAM)
IL (1) IL201901A0 (OSRAM)
WO (1) WO2008142572A2 (OSRAM)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010100414A1 (en) * 2009-03-04 2010-09-10 Orexo Ab Abuse resistant formulation
EA027618B1 (ru) 2009-05-08 2017-08-31 Эмпликюре Аб Композиция для непрерывной доставки лекарственного средства, содержащая геополимерное связующее
MX344141B (es) * 2010-02-26 2016-12-07 Toray Industries Preparacion solida recubierta.
ES2658913T3 (es) 2010-09-07 2018-03-12 Emplicure Ab Dispositivo de administración transdérmica de un fármaco
CN104523627B (zh) * 2014-12-18 2017-04-12 成都苑东生物制药股份有限公司 一种硫酸氢氯吡格雷片药物组合物及其制备方法
US10166185B2 (en) 2015-06-09 2019-01-01 J. Rettenmaier & Söhne Gmbh + Co Kg Excipient and oral solid dosage forms for oily drugs
WO2016201119A1 (en) * 2015-06-09 2016-12-15 J. Rettenmaier & Söhne Gmbh + Co Kg Excipient and oral solid dosage forms for oily drugs
WO2017149287A1 (en) * 2016-02-29 2017-09-08 Emplicure Ab Devices for evaporation and inhalation of active agents
CN105769798A (zh) * 2016-05-16 2016-07-20 张阳 一种高血压治疗药物的制备方法
CN105997915A (zh) * 2016-05-16 2016-10-12 张阳 一种高血压治疗用缓释片剂
GB201714412D0 (en) 2017-09-07 2017-10-25 Emplicure Ab Evaporation devices containing plant material
CN114146061B (zh) * 2020-09-07 2023-06-30 歌礼生物科技（杭州）有限公司 包含固体分散体的蛋白酶抑制剂增效组合物及其制备方法
CN114149011A (zh) * 2020-09-08 2022-03-08 浙江丰虹新材料股份有限公司 一种药用辅料硅酸铝镁及其合成方法
CA3246974A1 (en) * 2022-04-01 2023-10-05 Emplicure Ab Publ ALKALINE INTRAORAL PRODUCTS

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS53148519A (en) * 1977-05-31 1978-12-25 Sumitomo Chem Co Ltd Preparation of solid medicine containing gefarnate
JPS58109411A (ja) * 1981-12-23 1983-06-29 Shionogi & Co Ltd ニフエジピン固型製剤組成物
FI20021701L (fi) * 1991-01-30 2002-09-24 Wellcome Found Veteen dispergoituvia tabletteja
DE69727922T2 (de) * 1996-04-16 2005-01-20 Novartis Consumer Health S.A. Schnell zerfallende orale dosierungsform
JPH11286438A (ja) * 1998-03-31 1999-10-19 Shiseido Co Ltd 徐放性製剤
IL143846A0 (en) * 1998-12-23 2002-04-21 Alza Corp Dosage forms comprising porous particles
TW471968B (en) * 1999-08-25 2002-01-11 Committee On Chinese Medicine Solamargine pharmaceutical composition for killing cancer cells
AU2001246883B2 (en) * 2000-04-11 2004-08-12 Sankyo Company, Limited Stabilized pharmaceutical compositions containing calcium channel blockers
AR030557A1 (es) * 2000-04-14 2003-08-27 Jagotec Ag Una tableta en multicapa de liberacion controlada y metodo de tratamiento
US20030203029A1 (en) * 2001-12-14 2003-10-30 Wong Patrick S.-L. Controlled release liquid active agent formulation dosage forms
IL153277A0 (en) * 2002-12-04 2003-07-06 Pharmos Corp High enantiomeric purity dexanabinol for pharmaceutical compositions
WO2004082679A1 (ja) * 2003-03-17 2004-09-30 Takeda Pharmaceutical Company Limited 放出制御組成物
US20050181049A1 (en) * 2003-11-19 2005-08-18 Dong Liang C. Composition and method for enhancing bioavailability
CA2547657A1 (en) * 2003-12-01 2005-06-16 Lifecycle Pharma A/S Pharmaceutical compositions comprising lercanidipine
WO2005123040A1 (ja) * 2004-06-22 2005-12-29 Shionogi & Co., Ltd. 口腔内速崩壊錠
AU2005256322C1 (en) * 2004-06-28 2011-07-07 Veloxis Pharmaceuticals, Inc. Porous tablets as carriers for liquid formulations
CA2577583A1 (en) * 2004-08-19 2006-03-02 Alza Corporation Controlled release nanoparticle active agent formulation dosage forms and methods
US20060280789A1 (en) * 2004-12-27 2006-12-14 Eisai Research Institute Sustained release formulations
WO2006082523A2 (en) * 2005-01-25 2006-08-10 Aurobindo Pharma Limited Pharmaceutical sustained release composition of metformin

Also Published As

Publication number Publication date
JP2010527347A (ja) 2010-08-12
AU2008252481A1 (en) 2008-11-27
CN101677962B (zh) 2012-12-12
US20100196475A1 (en) 2010-08-05
CN101677962A (zh) 2010-03-24
EP2152248A2 (en) 2010-02-17
WO2008142572A2 (en) 2008-11-27
AU2008252481B2 (en) 2014-05-01
CA2684366A1 (en) 2008-11-27
WO2008142572A3 (en) 2009-02-12
GB0709541D0 (en) 2007-06-27

Similar Documents

Publication Publication Date Title
IL201901A0 (en) Controlled release tablet formulation containing magnesium aluminometasilicate
EP2242485A4 (en) ORAL TABLET WITH CONTROLLED RELEASE
PT2345410T (pt) Composição farmacêutica para libertação modificada
ZA201003723B (en) Tablet dispenser
SI2498759T1 (sl) Formulacije tablet s takojšnjim sproščanjem
ZA200900314B (en) Controlled release granules
EP2392512A4 (en) TABLE DISPENSING DEVICE
IL202103A0 (en) Controlled release pharmaceutical compositions for prolonged effect
EG26318A (en) Fertilizer formulation from which the active ingredients are controlled
EP2315816A4 (en) CUTTING MATERIALS
GB2449505B (en) Tablet dispenser
EP2124891A4 (en) CILOSTAZOL-CONTAINING PREPARATION WITH CONTROLLED RELEASE AND METHOD FOR THE PRODUCTION THEREOF
SI2040684T1 (sl) Večenotne tablete
EP1976490A4 (en) EXTENDED RELEASE TABLET CONTAINING ZALTOPROFEN AND PROCESS FOR PREPARING SAID TABLET
EP2217218A4 (en) ENHANCED TABLET COATING
ZA200904654B (en) Tablet formulation
LT2170348T (lt) Putojančios tabletės skirtos inhaliaciniam vartojimui
SI1952805T1 (sl) Tableta, ki vsebuje hidrogenirane fosfolipide
ZA201104564B (en) Low dosage controlled release tablet
HU0700485D0 (en) Pharmaceutical composition with controlled release containing tolperisone
GB0605104D0 (en) Tablet dispenser
ZA200805980B (en) Fast release granules
GB0608465D0 (en) Tablet dispenser
GB0705023D0 (en) Controlled release system
ZA200806897B (en) Fast release granules